Scapa Healthcare Announces Expansion of Sterilisation Irradiation Services in the UK
Proven Track Record of Technical Expertise Supporting Customers’ Product Sterility Requirements WINDSOR, Conn., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Scapa...
Year: 2020
ASLAN Pharmaceuticals to Present at Upcoming Piper Sandler Investor Conference
SINGAPORE, Nov. 19, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to...
Teneobio Announces the Presentation of Interim Phase I Data on TNB-383B (Anti-BCMAxCD3) at the 62nd Annual Meeting of the American Society of Hematology
NEWARK, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Teneobio Inc., a clinical stage biotech company focused on discovery and development...
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002
Trial to Evaluate Ability of BP1002, Targeting Bcl-2 Protein, to Treat Refractory/Relapsed Lymphoma and Chronic Lymphocytic Leukemia Patients HOUSTON, Nov....
Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
BOSTON and LONDON, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced...
Aravive Announces Phase 3 Trial Design for AVB-500 in Platinum Resistant Ovarian Cancer
Pivotal Trial Expected to be Initiated During 1Q21 HOUSTON, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage...
EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4
WATERTOWN, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing...
Freeline to present at the 3rd Annual Evercore ISI Health CONx Conference
LONDON, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully...
Ocuphire Pharma Announces First Patient Enrolled in MIRA-2 Phase 3 Clinical Trial Investigating Nyxol® for Reversal of Mydriasis
Begins Enrollment in the First of Four Upcoming Late-Stage Trials in the U.S. Announces MIRA-1 Phase 2b Study Accepted for...
Baudax Bio Announces an additional Orange Book listed patent for ANJESO®
MALVERN, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute...
Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting
New Findings Show UroLift System Same-Day Outpatient Procedure Demonstrates Symptom Improvement for Benign Prostatic Hyperplasia WAYNE, Pa., Nov. 19, 2020...
Apellis and Sobi Announce First Patient Dosed in Potentially Registrational ALS Study of Pegcetacoplan
52-week Phase 2 MERIDIAN study to evaluate pegcetacoplan, a targeted C3 therapy, in approximately 200 adults with ALS WALTHAM, Mass....
Electromedical Technologies Produces $4.2 Million in Device Inventory to Meet Demand
- Company completes production of 1,200 FDA-cleared WellnessPro+ devices - Inventory build completed ahead of on-boarding new medical practitioners and...
Entera Bio Ltd Announces Third Quarter 2020 Financial Results and Provides Clinical Update
‒ Completed Enrollment in Phase 2 Clinical Trial of EB613, Positioned as the First Potential Oral Bone Building Product to...
LIDDS Interim report January – September 2020
JANUARY – SEPTEMBER 2020 Net sales amounted to MSEK 0.0 (0.0) Operating expenses amounted to MSEK -19.8 (-22.9) Profit/loss before...
Anteris Technologies to Present at Credit Suisse Structural Heart Forum on November 23, 2020
BRISBANE, Australia and EAGAN, Minn., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Anteris Technologies Ltd (ASX:AVR) (Anteris or the Company), a...
Sequana Medical Announces Positive Interim Data From North American Pivotal alfapump® Study (POSEIDON)
Results from first 13 patients in Roll-In Cohort showed over 90% reduction in mean frequency of therapeutic paracentesis versus baseline...
Modernizing Medicine Kicks Off MOMENTUM VIRTUAL 2020 Conference
Forward-thinking leaders, health care practices and professionals come together to collaborate and innovate at free virtual industry event this weekend...
Tal Rosenberg to Lead Real World Data at Ciox Health
25-year life sciences and technology veteran named President of Ciox RWD business ALPHARETTA, Ga.--(BUSINESS WIRE)--Ciox, a leading health technology company,...
Tablo Hemodialysis Systems Deployed to Guam Hospitals by U.S. Department of Health and Human Services for Emergency Response
Guam to receive HHS emergency deployment of Outset Medical’s mobile, easy-to-use dialysis technology for patients with kidney failure. SAN JOSE,...